BackgroundHepatic resection has evolved to become safer, thereby making it possible to
expand the indications.AimTo assess the results from a group of patients presenting these expanded
indications.MethodWere prospectively studied all the hepatectomy procedures performed for hepatic
tumor resection. Patients with benign and malignant primary and secondary tumors
were included. Were included variables such as age, gender, preoperative
diagnosis, preoperative treatment, type of operation performed, need for
transfusion, final anatomopathological examination and postoperative evolution.
The patients were divided into two groups: group A, with a traditional indication
for hepatectomy; and group B, with an expanded indication (tumors in both hepatic
lobes, extensive resection encompassing five or more segments, cirrhotic livers
and postoperative chemotherapy using hepatotoxic drugs).ResultsWere operated 38 patients, and 40 hepatectomies were performed: 28 patients in
group A and 10 in group B. The mean age was 57.7 years, and 25 patients were
women. Three in group B were operated as two separate procedures. Groups A and B
received means of 1.46 and 5.5 packed red blood cell units per operation,
respectively. There were three cases with complications in group A (10.7%) and six
in group B (60%). The mortality rate in group A was 3.5% (one patient) and in
groups B, 40% (four patients). The imaging examinations were sensitive for the
presence of tumors but not for defining the type of tumor. The blood and
derivative transfusion rates, morbidity and mortality were greater in the group
with expanded indications and more extensive surgery.ConclusionThe indications for liver biopsy and portal vein embolization or ligature can be
expanded, with special need of cooperation of the anesthesiology department and
the use of hepatic resection devices to diminish blood transfusion.